Minerva Neurosciences Inc (NERV) is not a strong buy at this moment for a beginner, long-term investor with $50,000-$100,000 to invest. The lack of positive financial performance, absence of trading signals, and no significant catalysts make it prudent to hold off on purchasing this stock right now.
The MACD is negatively expanding, indicating bearish momentum. RSI is neutral at 32.483, and moving averages show a bullish crossover (SMA_5 > SMA_20 > SMA_200). However, the pre-market price is down 2.36%, and the stock is trading near its S1 support level of 5.39.
NULL identified. No recent news or significant events to drive positive sentiment.
Pre-market price is down 2.36%. Financial performance shows a significant drop in net income and EPS (-112.19% YoY and -112.12% YoY, respectively). No recent insider or hedge fund activity to indicate confidence in the stock.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped significantly to -2,743,954 (-112.19% YoY), and EPS fell to -0.36 (-112.12% YoY). Gross margin remains at 0.
No data on analyst ratings or price target changes.